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Background
Group B streptococci or S.agalactiae
 Since the 1970s, leading cause of life-
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Prevention of perinatal GBS EOD
 Intrapartum antibiotics
 Highly effective at preventing EOD in women at risk of
transmitting GBS to their newborns ( > 4 h)
INTRAPARTUM ANTIMICROBIAL 
PROPHYLAXIS 
Main goal : 
 To prevent 70 to 80 % of GBS EO cases
Secondary :
 To reduce peripartum maternal morbidity
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Concerns
 Increase of resistance to erythromycin
and clindamycin
 Susceptibility to penicillin
 Very few R isolates recently characterized in 
Japan
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Objectives
Among GBS recently isolated in Belgium
 From adults with severe infections
 From early or late onset neonatal diseases
 To monitor penicillin susceptibility
 To determine rates of erythomycin and
clindamycin resistance
 To assess the distribution of macrolide resistance
phenotypes
 To identify genes coding for resistance to 
erythromycin
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Methods : Isolates
 Clinical isolates
 Sent to the Belgian reference laboratory for GBS from January
2005 and June 2006
 From blood, CSF or any deep normally sterile site
 178 isolates
 22 from neonatal EOD
 10 from neonatal LOD
 146 from adult invasive disease
 Serotypes
 Ia (17%); Ib (6%); II (10%); III (33%); IV (6%); V (21%); others (7%)
 Reference strains
 Positive either for ermB, ermTR or mefA genes
 Negative for these 3 genes
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Methods : Susceptibility testing
 Disk diffusion 
 For all isolates
 Erythromycin (15 µg) and clindamycin (2 µg) disks
 18 mm apart
 Etest
 Benzylpenicilline strips
 For all isolates
 Erythromycin and clindamycin strips
 For all erythromycin resistant isolates
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Interpretation criteria (MH with blood)
(CLSI 2006)
Zone MIC  
Diameter (mm) (mg/L)
S     I     R S   I   R
Penicillin > 24 - - < 0.12 - -
Erythromycin > 21 16-20 < 15 < 0.25 0.5 > 1
Clindamycin > 19 16-18 < 15 < 0.25 0.5 > 1
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Methods : Detection of R genes
 DNA extraction 
 QIAmp DNA Mini Kit (Qiagen)
 PCR amplification with specific primers and protocols
 Detection of ermB, ermTR and mefA genes
 Caracterisation of PCR products
 Separation by electrophoresis
 2% Agarose gel + ethidium bromide staining







PCR Product sizes (bp)Targets
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Results
Antimicrobial susceptibility profile of 
178 GBS clinical isolates
% of Resistance MIC90 MIC Range 
(mg/L) (mg/L)
Penicillin* 0 0.094 0.016-0.094
Erythromycin 32
Clindamycin 19 (25**)
* : same interpretation for ampicillin and cefazolin
**: iMLS resistant phenotype included
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Results
Erythromycin and clindamycin resistance
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Results
Erythromycin resistance among


































 cMLS Erythro R & Clinda R
 iMLS Erythro R & Clinda S/I/R  with Dtest +
 M Erythro R & Clinda S         with Dtest -
4  /  1221 M
4  /  >25634 Inducible
>256  /  >25645ConstitutiveMLS
Ery MIC50 / MIC90              
(mg/L)
%Phenotype
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Conclusion
 All GBS isolates fully susceptible to penicillin 
 Increase of resistance to macrolides : a relevant 
problem.
 Level: similar to rates observed in France, a neighbour
country.
 No more difference  among isolates from either adults or 
neonates.  
 Most of macrolide R isolates had a MLS phenotype.  
 Detection of MLS-IR is important 
 simple and reliable double-disk diffusion test strongly 
recommended.
 Neither macrolides no lincosamides should no longer 
be used without susceptibility testing.
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